Pàgina inicial > Resultats de la cerca: Amir, Eitan
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 5 registres trobats en 0.03 segons.
Articles, 5 registres trobats
Articles 5 registres trobats  
1.
9 p, 975.2 KB Association between control group therapy and magnitude of clinical benefit of cancer drugs / Molto, Consolacion (Princess Margaret Cancer Centre and University of Toronto. Division of Medical Oncology and Hematology, Department of Medicine) ; Tibau Martorell, Ariadna (Institut d'Investigació Biomèdica Sant Pau) ; Bujosa, Aida (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ; Tapia, Jose Carlos (Institut d'Investigació Biomèdica Sant Pau) ; Mittal, Abhenil (Princess Margaret Cancer Centre and University of Toronto. Division of Medical Oncology and Hematology, Department of Medicine) ; Tamimi, Faris (Princess Margaret Cancer Centre and University of Toronto. Division of Medical Oncology and Hematology, Department of Medicine) ; Amir, Eitan (Princess Margaret Cancer Centre and University of Toronto. Division of Medical Oncology and Hematology, Department of Medicine) ; Universitat Autònoma de Barcelona
Little is known about the impact of control group therapy on clinical benefit scales such as American Society of Clinical Oncology Value Framework (ASCO-VF), European Society for Medical Oncology Magnitude Clinical Benefit Scale (ESMO-MCBS), National Comprehensive Cancer Network (NCCN) Evidence Blocks and ASCO Cancer Research Committee (ASCO-CRC). [...]
2022 - 10.1038/s41598-022-25983-9
Scientific reports, Vol. 12 (december 2022)  
Registre complet - Creative Commons
2.
13 p, 1.7 MB Clinical benefit of cancer drugs approved in Switzerland 2010-2019 / Adam, Roman (Faculty of Medicine. University of Basel) ; Tibau Martorell, Ariadna (Institut d'Investigació Biomèdica Sant Pau) ; Valiente, C.M. (Institut d'Investigació Biomèdica Sant Pau) ; Šeruga, Bostjan (Univerza V Ljubljani) ; Ocaña, Alberto (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) ; Amir, Eitan (University of Toronto, Canada) ; Templeton, Arnoud (St. Clara Research Ltd.)
Background It is unknown to what extent cancer drugs approved in Switzerland by the Swissmedic fulfil criteria of clinical benefit according to the European Society of Medical Oncology Magnitude of Clinical Benefit Scale version 1. [...]
2022 - 10.1371/journal.pone.0268545
PloS one, Vol. 17 Núm. 6 June (june 2022) , p. e0268545  
Registre complet - Creative Commons
3.
10 p, 328.7 KB Fragility of randomized trials supporting cancer drug approvals stratified by approval pathway and review designations / Wilson, B.E. (University of New South Wales) ; Desnoyers, A. (Princess Margaret Cancer Centre. Department of Medical Oncology. University of Toronto) ; Nadler, M.B. (Princess Margaret Cancer Centre. Department of Medical Oncology. University of Toronto) ; Tibau Martorell, Ariadna (Institut d'Investigació Biomèdica Sant Pau) ; Amir, Eitan (Princess Margaret Cancer Centre. Department of Medical Oncology. University of Toronto) ; Universitat Autònoma de Barcelona
Background: It has been suggested that the results from fragile trials are less likely to translate into benefit in routine clinical practice. Methods: We searched the Food and Drug Administration (FDA) archives to identify drug approvals for solid organ malignancies between 2010 and 2019. [...]
2021 - 10.1002/cam4.4029
Cancer Medicine, Vol. 10 Núm. 16 (august 2021) , p. 5405-5414  
Registre complet - Creative Commons
4.
11 p, 290.2 KB Interaction between Hormonal Receptor Status, Age and Survival in Patients with BRCA1/2 Germline Mutations : A Systematic Review and Meta-Regression / Templeton, Arnoud (University Basel, Switzerland) ; Gonzalez, Laura Diez (Complejo Hospitalario Universitario de Albacete) ; Vera-Badillo, Francisco E. (Department of Oncology, Queen's University, Kingston Canada) ; Tibau Martorell, Ariadna (Institut d'Investigació Biomèdica Sant Pau) ; Goldstein, Robyn (University of Toronto, Canada) ; Šeruga, Boštjan (Institute of Oncology, Ljubljana, Slovenia) ; Srikanthan, Amirrtha (University of Toronto, Canada) ; Pandiella, Atanasio (Universidad de Salamanca) ; Amir, Eitan (University of Toronto, Canada) ; Ocana, Alberto (Complejo Hospitalario Universitario de Albacete) ; Universitat Autònoma de Barcelona
Germline mutations in the BRCA1 and BRCA2 genes are the most frequent known hereditary causes of familial breast cancer. Little is known about the interaction of age at diagnosis, estrogen receptor (ER) and progesterone receptor (PgR) expression and outcomes in patients with BRCA1 or BRCA2 mutations. [...]
2016 - 10.1371/journal.pone.0154789
PloS one, Vol. 11 (may 2016)  
Registre complet - Creative Commons
5.
7 p, 951.5 KB Role of cooperative groups and funding source in clinical trials supporting guidelines for systemic therapy of breast cancer / Tibau Martorell, Ariadna (Institut d'Investigació Biomèdica Sant Pau) ; Anguera, Georgia (Institut d'Investigació Biomèdica Sant Pau) ; Andrés-Pretel, Fernando (Research Foundation of the Paraplegics Hospital of Toledo, Toledo, Spain) ; Templeton, Arnoud (University of Basel, Basel, Switzerland) ; Seruga, Bostjan (Institute of Oncology Ljubljana and University of Ljubljana, Ljubljana, Slovenia) ; Barnadas i Molins, Agustí (Institut d'Investigació Biomèdica Sant Pau) ; Amir, Eitan (University of Toronto, Toronto, Ontario, Canada) ; Ocana, Alberto (Complejo Hospitalario Universitario de Albacete) ; Universitat Autònoma de Barcelona
Clinical research is conducted by academia, cooperative groups (CGs) or pharmaceutical industry. Here, we evaluate the role of CGs and funding sources in the development of guidelines for breast cancer therapies. [...]
2018 - 10.18632/oncotarget.24589
Oncotarget, Vol. 9 (february 2018) , p. 15061-15067  
Registre complet - Creative Commons

Vegeu també: autors amb noms similars
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem